Dr. Kitonga Peter Kiminyo, MD

Dr. Kiminyo practices at ID Consultants Inc in Boynton Beach, Florida.

Dr. Kiminyo's NPI, 1649373101, was assigned on September 7, 2006. Dr. Kiminyo graduated from Howard University College Of Medicine in 1997. Dr. Kiminyo holds Florida license ME0086064.

Dr. Kiminyo's primary practice is ID Consultants Inc, at 2300 S Congress Ave, Boynton Beach, FL 33426 in Palm Beach County. The practice phone is (561) 735-7531.

Dr. Kiminyo's primary practice is ID Consultants Inc in Boynton Beach, Florida. Dr. Kiminyo is also affiliated with Bethesda Hospital East. The medical group on file is ID Consultants Inc. Dmand AI also links Dr. Kiminyo to 4 more hospitals, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kiminyo practices, 8 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kiminyo's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kiminyo is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Kiminyo's licenses on file in 2 states: Florida and District of Columbia.

Dmand AI lists acute skin infection, facial skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Kiminyo treats.

CMS data shows 75,306 Medicare services from Dr. Kiminyo across 17 procedure codes in 2024, for 1,169 Medicare patients. Medicare paid $489,183 for them.

CMS counts 1,169 Medicare patients who saw Dr. Kiminyo in 2024. The largest group is 75 to 84, with 427 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kiminyo's median patient age at 63, with 49% women.

In 2024, Dr. Kiminyo wrote 1,108 Medicare Part D claims for 283 patients. 50% of them were for generic drugs. CMS names the drug for 943 of them, across 23 drugs with 11 or more claims each, at $1,545,799 in total drug cost. In 2023, CMS named 539 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kiminyo for performance year 2024, reported as part of a group. Dr. Kiminyo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kiminyo as offering telehealth.

Dmand AI links 3 papers to Dr. Kiminyo. The most frequent topics are Electron Spin Resonance Spectroscopy and Free Radicals. Dr. Kiminyo's most frequent co-author is Arthur G. Spector, MD.

CMS Open Payments shows 271 general payments to Dr. Kiminyo from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,158.

Dmand AI lists 1 award for Dr. Kiminyo, most recently Top Infectious Disease physicians in 2017.

Dr. Kiminyo graduated from Howard University College Of Medicine in 1997.

Dr. Kiminyo is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.